Noriho Sakamoto

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

Interstitial Pneumonia Associated with Linear Immunoglobulin A/Immunoglobulin G Bullous Dermatosis

Tomoyuki Kakugawa, Saori Tomimura, Tomayoshi Hayashi et al. · Respiration · 2013 · 298 citations · Full text

Clinical Differences Between Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis and Classic Dermatomyositis

Hiroshi Mukae, Hiroshi Ishimoto, Noriho Sakamoto et al. · CHEST Journal · 2009 · 196 citations

Advanced Lung Disease, Classic Dermatomyositis, Pathology +4

Pirfenidone inhibits the expression of HSP47 in TGF-β1-stimulated human lung fibroblasts

Seiko Nakayama, Hiroshi Mukae, Noriho Sakamoto et al. · Life Sciences · 2007 · 155 citations · Full text

Fibrosis, Lung Inflammation, Medicine +6

Alveolar macrophage-epithelial cell interaction following exposure to atmospheric particles induces the release of mediators involved in monocyte mobilization and recruitment

Hiroshi Ishii, Shizu Hayashi, James C. Hogg et al. · Respiratory Research · 2005 · 147 citations · Full text